Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 2422

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 2422
---
 officers 

    Francis Knuettel II (2) 
     285,232  
     4.6%

    Ezra Friedberg (3) 
     568,084  
     9.4%

    Todd Davis (4) 
     136,300  
     2.2%

    Richard Malamut (5) 
     47,365  
     *%

    Chia-Lin Simmons (6) 
     47,083  
     *%

    Eric Lang (7) 
     62,880  
     1.0%

    All executive officers and directors as a group (6 persons) 
     1,145,212  
     17.9%

    5% or greater stockholders: 

    Alexandra Wood (Canada) Inc. (8) 
     574,187  
     9.5%

    Boswell Prayer Ltd (9) 
     471,592  
     7.8%

    Motif Pharmaceuticals Ltd. (10) 
     483,406  
     8.0%

    Balmoral Financial Group LLC (11) 
     520,719  
     8.6%

    AME Equities LLC (12) 
     369,178  
     6.1%

    Aperture Healthcare Ventures Ltd. (13) 
     444,071  
     7.4%

    Benuvia Operations, LLC (15) 
     384,226  
     6.4%

96 

    *
    Less than 1%

    (1)
    Except as otherwise
    indicated, the persons named in the table above have sole voting and investment power with respect to all shares of Common
    Stock shown as beneficially owned by them.

    (2)
    For Mr. Knuettel,
    includes 22,223 shares of Common Stock issuable upon the exercise of stock options which are exercisable for shares of Common
    Stock at a price of $22.68 per share, 2,778 shares of Common Stock issuable upon the exercise of stock options which are exercisable
    for shares of Common Stock at a price of $22.68 per share, 27,778 shares of Common Stock issuable upon the exercise of stock
    options which are exercisable for shares of Common Stock at a price of $22.68